CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-09-10 | NIGALAYE ASHOK G Scief Scientific Officer | Conversion · Series E Convertible Preferred Stock | −1,600 | 0 | ||
| 2013-09-10 | EPIC PHARMA LLC 10% owner | Conversion | +65,843,621 | $0.02 | $1.6M | 74,851,833 |
| 2013-09-10 | EPIC PHARMA LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −1,600 | 0 | ||
| 2013-09-10 | EPIC INVESTMENTS, LLC 10% owner | Conversion | +65,843,621 | $0.02 | $1.6M | 74,851,833 |
| 2013-09-10 | EPIC INVESTMENTS, LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −1,600 | 0 | ||
| 2013-07-23 | Plassche Douglas Senior VP of Operations | Grant or award · Options | +3,000,000 | 3,000,000 | ||
| 2013-05-09 | NIGALAYE ASHOK G Chief Scientific Officer | Returned to the company | −391,500 | $0.07 | $28K | 21,063,395 |
| 2013-05-09 | NARINE JEENARINE Director | Returned to the company | −391,500 | $0.07 | $28K | 14,965,834 |
| 2013-05-09 | POTTI RAM 10% owner | Returned to the company | −391,500 | $0.07 | $28K | 15,235,392 |
| 2013-05-09 | EPIC PHARMA LLC 10% owner | Returned to the company | −391,500 | $0.07 | $28K | 9,008,212 |
| 2013-05-09 | EPIC INVESTMENTS, LLC 10% owner | Returned to the company | −391,500 | $0.07 | $28K | 9,008,212 |
| 2013-04-29 | NIGALAYE ASHOK G Chief Scientific Officer | Returned to the company | −140,000 | $0.08 | $11K | 30,366,536 |
| 2013-04-29 | NARINE JEENARINE Director | Returned to the company | −140,000 | $0.08 | $11K | 24,268,978 |
| 2013-04-29 | POTTI RAM Director | Returned to the company | −140,000 | $0.08 | $11K | 24,538,536 |
| 2013-04-29 | EPIC PHARMA LLC 10% owner | Returned to the company | −140,000 | $0.08 | $11K | 9,399,712 |
| 2013-04-29 | EPIC INVESTMENTS, LLC 10% owner | Returned to the company | −140,000 | $0.08 | $11K | 9,399,712 |
| 2013-04-29 | POTTI RAM 10% owner | Returned to the company | −130,000 | $0.08 | $10K | 24,538,546 |
| 2013-04-29 | POTTI RAM 10% owner | Other disposition | −13,367,481 | $0.04 | $493K | 15,626,892 |
| 2013-04-29 | NARINE JEENARINE Director | Returned to the company | −130,000 | $0.08 | $10K | 24,268,988 |
| 2013-04-29 | NARINE JEENARINE Director | Other disposition | −13,367,481 | $0.04 | $493K | 15,357,334 |
Page 14 of 18 · 356 trades